BMS453

Known as: BMS 453, BMS-453 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2014
01219992014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Breast cancer is the most common malignancy in women and the appearance of distant metastases produces the death in 98% of cases… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2003
2003
Fusion and hypoplasia of the first two branchial arches, a defect typically observed in retinoic acid (RA) embryopathy, is… (More)
Is this relevant?
2002
2002
Retinoids are potent antiproliferative and anti-inflammatory compounds. We previously demonstrated that the natural pan-agonists… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2001
2001
We have previously shown that a retinoic acid receptor (RAR) antagonist BMS453, which does not activate RAR-dependent gene… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
OBJECTIVE To investigate the effects of RARbeta selective agonist and RARalpha antagonist (RARbeta +/RARalpha -) BMS453 in… (More)
Is this relevant?
1999
1999
To elucidate the role of RAR–dependent gene transcription in inhibiting breast cell growth, we have investigated the ability of… (More)
  • table 1
  • figure 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?